Fulgent Genetics Inc
NASDAQ:FLGT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zhang Jia Jie Tourism Group Co Ltd
SZSE:000430
|
CN |
Fulgent Genetics Inc
Cost of Revenue
Fulgent Genetics Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Fulgent Genetics Inc
NASDAQ:FLGT
|
Cost of Revenue
-$191.8m
|
CAGR 3-Years
9%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cost of Revenue
-$7.5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-5%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cost of Revenue
-$346.7B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-11%
|
|
|
Cigna Corp
NYSE:CI
|
Cost of Revenue
-$249.3B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-26%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cost of Revenue
-$9.9B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-6%
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Cost of Revenue
-$349m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
Fulgent Genetics Inc
Glance View
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. The company is headquartered in Temple City, California and currently employs 645 full-time employees. The company went IPO on 2016-09-28. The firm develops a technology platform, which offers a test menu. The company performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels. Its test offerings also include Solid Tumor Molecular Profiling for somatic cancer testing, Rapid Whole Genome testing developed for children in neonatal intensive care units or pediatric intensive care units its Newborn Genetic Analysis panel, and a single front-line test designed to comprehensively detect ataxia-related variants. The company also offers certain research service tests, which are ordered by research institutions and other similar institutional customers.
See Also
What is Fulgent Genetics Inc's Cost of Revenue?
Cost of Revenue
-191.8m
USD
Based on the financial report for Dec 31, 2025, Fulgent Genetics Inc's Cost of Revenue amounts to -191.8m USD.
What is Fulgent Genetics Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-16%
Over the last year, the Cost of Revenue growth was -9%. The average annual Cost of Revenue growth rates for Fulgent Genetics Inc have been 9% over the past three years , -16% over the past five years .
